Rare opportunity for precise "top escaping"? After ten years, hongda high-tech holding reduces shareholding in haining china leather market | Quick announcement reading.

① Hongda high-tech holding sold 11.15 million shares of Haining China Leather Market, with a transaction amount of 71.65 million yuan. ② The company holds a total of 30.3 million shares of Haining China Leather Market, which were acquired before the initial public offering, with the lockup period lifted and listed for circulation in 2014, and it has been ten years since then. ③ There has been unusual stock price movement in Haining China Leather Market over the past ten days, with five consecutive limit ups from November 15 to November 21, followed by a rapid decline from November 25 to 27, with today's closing price at 4.88 yuan.

cls.cnNov 27 22:11

After a 10-year wait! hongda high-tech holding "seizes market opportunities" to reduce shareholding in haining china leather market.

1. Hongda high-tech holding announced that it recently sold part of its stocks in haining china leather market for a total amount of 71.6589 million yuan, accounting for 0.87% of haining china leather market's total equity. 2. After the shareholding, hongda high-tech holding still holds 19.15 million shares of haining china leather market, accounting for 1.49% of the total equity.

cls.cnNov 27 20:56

Huawei Mate 70 series is coming, which core suppliers of A-shares are worth paying attention to?

1. Huawei officially launched the Mate 70 series, starting at 5499 yuan; 2. The market expects that this series will become another important flagship product for Huawei, with many institutions predicting sales of over tens of millions; 3. Core suppliers such as boe technology group, visionox technology inc., lens technology, and ofilm group co., ltd are worth paying attention to.

cls.cnNov 26 18:27

Abnormal trading investigation! The big bull stock special treat Jingfeng has been suspended for the first time, with an increase of over 752% in more than four months | Quick read of the announcement.

①*ST Jingfeng suspended trading for the first time this year due to abnormal fluctuations; ② The cumulative deviation of the closing price for two consecutive trading days reached 15.39%; ③ The stock price has increased by 752.78% in the past four months; ④ There is still uncertainty about the highly anticipated pre-restructuring matters.

cls.cnNov 17 19:31

Q3 earnings have increased year-on-year, fosun pharma promotes the sales of botulinum toxin products domestically | Direct coverage of the earnings conference.

① During the earnings conference, fosun pharma stated that the company's performance improved year-on-year in Q3 due to factors such as the continuous increase in innovative drug volume. ② Chief financial officer Chen Zhanyu revealed that the company is actively promoting the rapid上市 and sales of injectable type A botulinum toxin within china. ③ The privatization process of henlius and the accessibility of CAR-T products are also receiving significant attention.

cls.cnNov 13 21:52

Foreign public fund latest hold positions exposure! Fund managers are bullish on china's stock market valuation repair.

With the disclosure of the third quarter report, public funds under international asset management giants such as BlackRock and Fidelity have all their holdings exposed.

Securities TimesOct 29 10:07